SpliSense Israeli Company
SpliSense is a clinical stage company developing transformative RNA-based treatments for unmet needs relating to diverse pulmonary diseases. Its treatment is based on clinically validated Antisense Oligonucleotide (ASO) technology, delivered non-invasively by inhalation to the lungs.
Health Tech & Life Sciences
Biotechnology
Life Science
Pharmaceutical
Alternatives
No alternatives listed yet.
Suggest an Alternative
Founders
Parent Companies/Investors
Office Locations
Jerusalem, Israel
References
[1]
finder.startupnationcentral.org
- https://finder.startupnationcentral.org/company_page/splisense
[2]
crunchbase.com
- https://www.crunchbase.com/organization/splisense
External links are provided for reference and verification purposes.